References
- Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, . Sympathetic augmentation in hypertension: Role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension. 2004;43:169–175.
- Chrousos GP, Kino T. Glucocorticoid signaling in the cell. Ann N Y Acad Sciences. 2009;1179:153–166.
- Kurata M, Okura T, Irita J, Enomoto D, Nagao T, Jotoku M, . The relationship between osteopontin and adiponectin in patients with essential hypertension. Clin Exp Hypertens. 2010;32:358–363.
- Okura T, Jotoku M, Irita J, Enomoto D, Nagao T, Desilva V, . Association between cystatin C and inflammation in patients with essential hypertension. Clin Exp Nephrol. 2010;14:584–588.
- Yu X, Yang Z, Yu M. Correlation of tumor necrosis factor alpha and interleukin 6 with hypertensive renal damage. Ren Fail. 2010;32:475–479.
- Timasheva Y, Nasibullin T, Zakirova A, Mustafina O. Association of interleukin-6, interleukin-12, and interleukin-10 gene polymorphisms with essential hypertension in Tatars from Russia. Biochem Genetics. 2008;46:64–74.
- Garrido-Sánchez L, García-Fuentes E, Cardona F, Rojo-Martínez G, Soriguer F, Tinahones FJ. Anti-oxidized LDL antibody levels are reduced in women with hypertension. Eur J Clin Invest. 2009;39:800–806.
- Ishmael JE, Löhr CV, Fischer K, Kioussi C. Localization of myosin II regulatory light chain in the cerebral vasculature. Acta Histochemica. 2008;110:172–177.
- Bethunaickan R, Berthier CC, Ramanujam M, Sahu R, Zhang W, Sun Y, . A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis. J Immunol. 2011;186:4994–5003.
- Basu A, Chaturvedi UC. Vascular endothelium: The battlefield of dengue viruses. FEMS Immunol Med Microbiol. 2008;53:287–299.
- Mersich AT, Miller MR, Chkourko H, Blystone SD. The formin FRL1 (FMNL1) is an essential component of macrophage podosomes. Cytoskeleton. 2010;67:573–585.
- Bartoloni E, Alunno A, Luccioli F, Moscatelli S, Biscontini D, Santoboni G, . Atherosclerotic vascular damage and rheumatoid arthritis: A complex but intriguing link. Expert Rev Cardiovasc Ther. 2010;8:1309–1316.
- Louden C, Brott D, Katein A, Kelly T, Gould S, Jones H, . Biomarkers and mechanisms of drug-induced vascular injury in non-rodents. Toxicologic Pathol. 2006;34:19–26.
- Lopez B, Querejeta R, Varo N, Gonzalez A, Larman M, Martinez Ubago JL, . Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation. 2001;104:286–291.
- Mori T, Kai H, Kajimoto H, Koga M, Kudo H, Takayama N, . Enhanced cardiac inflammation and fibrosis in ovariectomized hypertensive rats: A possible mechanism of diastolic dysfunction in postmenopausal women. Hypertens Res. 2011;34:496–502.
- Cuspidi C, Meani S, Salerno M, Severgnini B, Fusi V, Valerio C, . Cardiovascular risk stratification according to the. 2003 ESH‐ESC guidelines in uncomplicated patients with essential hypertension: Comparison with the 1999 WHO/ISH guidelines criteria. Blood Press. 2004;13:142–151.
- Tarnacka B, Gromadzka G, Czlonkowska A. Increased circulating immune complexes in acute stroke: The triggering role of Chlamydia pneumoniae and cytomegalovirus. Stroke. 2002;33:936–940.
- Mustafa A, Nityanand S, Berglund L, Lithell H, Lefvert AK. Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarction. Circulation. 2000;102:2576–2581.
- Lukacs NW, Glovsky MM, Ward PA. Complement- dependent immune complex-induced bronchial inflammation and hyperreactivity. Am J Physiol Lung Cell Mol Physiol. 2001;280:L512–L518.
- Lip GYH, Edmunds E, Martin SC, Jones AF, Blann AD, Beevers DG. A pilot study of homocyst(e)ine levels in essential hypertension: Relationship to von Willebrand factor, an index of endothelial damage. Am J Hypertens. 2001;14:627–631.
- Spencer CGC, Gurney D, Blann AD, Beevers DG, Lip GYH. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Hypertension. 2002;40:61–66.
- Sunderkötter C. Vasculitis of small blood vessels – Some riddles about IgA and about the complexity of transmigration. Exp Dermatol. 2009;18:91–96.
- Kai H, Mori T, Tokuda K, Takayama N, Tahara N, Takemiya K, . Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II. Hypertens Res. 2006;29:711–718.
- González A, López B, Ravassa S, Beaumont J, Arias T, Hermida N, . Biochemical markers of myocardial remodelling in hypertensive heart disease. Cardiovascular Res. 2009;81:509–518.
- Yu Q, Horak K, Larson DF. Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling. Hypertension. 2006;48:98–104.
- Kuwahara F, Kai H, Tokuda K, Niiyama H, Tahara N, Kusaba K, . Roles of intercellular adhesion molecule-1 in hypertensive cardiac remodeling. Hypertension. 2003;41:819–823.
- Booz GW. Impact of T lymphocytes on cardiac remodeling in hypertension: More questions than answers. Hypertension. 2006;48:31–32.
- Rocnik EF, Chan BM, Pickering JG. Evidence for a role of collagen synthesis in arterial smooth muscle cell migration. J Clin Invest. 1998;101:1889–1898.